1. CHMP meeting highlights September 2021: Vaxzevria-related TTS

   News item 02 October 2021 Pages: 1 - 1

2. Eli Lilly recalls one lot of glucagon in USA and Canada due to health risks

   News item 02 October 2021 Pages: 2 - 2

3. Pfizer recalls all lots of varenicline in USA due to nitrosamine

   News item 02 October 2021 Pages: 3 - 3

4. Pregnancy category adjusted for carbimazole and propylthiouracil

   News item 02 October 2021 Pages: 4 - 4

5. Product monographs for COVID-19 vaccines updated in Canada

   News item 02 October 2021 Pages: 5 - 5

6. Revised labelling for istradefylline in Japan

   News item 02 October 2021 Pages: 6 - 6

7. Revised labelling for lomitapide mesilate in Japan

   News item 02 October 2021 Pages: 7 - 7

8. Santen's ciclosporin eye drops (Ikervis) recalled in UK due to detection of particles/crystals

   News item 02 October 2021 Pages: 8 - 8

9. AED exposure associated with poorer functional status after stroke

   Clinical study 02 October 2021 Pages: 9 - 9

10. FAPIC score predicts mortality after COVID-19 vaccine-related TTS

    Clinical study 02 October 2021 Pages: 10 - 10

11. Long-term oral anticoagulant use for VTE: risk of haemorrhage

    Clinical study 02 October 2021 Pages: 11 - 11

12. Sarcopenia with glucose-lowering drugs

    Clinical study 02 October 2021 Pages: 12 - 12

13. Other adverse reaction research

    News item 02 October 2021 Pages: 13 - 13

14. Abacavir/atazanavir/lamivudine

    Case report 02 October 2021 Pages: 14 - 14

15. Abacavir/dolutegravir/lamivudine

    Case report 02 October 2021 Pages: 15 - 15

16. Abatacept/etanercept/tocilizumab

    Case report 02 October 2021 Pages: 16 - 16

17. Abemaciclib/bevacizumab/paclitaxel

    Case report 02 October 2021 Pages: 17 - 17

18. Acenocoumarol/warfarin

    Case report 02 October 2021 Pages: 18 - 18

19. Aciclovir

    Case report 02 October 2021 Pages: 19 - 19

20. Ad26.COV2-S

    Case report 02 October 2021 Pages: 20 - 20

21. Adalimumab/etanercept/infliximab

    Case report 02 October 2021 Pages: 21 - 21

22. Albumin-human/plasma

    Case report 02 October 2021 Pages: 22 - 22

23. Alemtuzumab

    Case report 02 October 2021 Pages: 23 - 23

24. Alemtuzumab

    Case report 02 October 2021 Pages: 24 - 24

25. Alemtuzumab

    Case report 02 October 2021 Pages: 25 - 25

26. Alemtuzumab/basiliximab

    Case report 02 October 2021 Pages: 26 - 26

27. Allopurinol

    Case report 02 October 2021 Pages: 27 - 27

28. Alprazolam

    Case report 02 October 2021 Pages: 28 - 28

29. Amiodarone

    Case report 02 October 2021 Pages: 29 - 29

30. Amiodarone

    Case report 02 October 2021 Pages: 30 - 30

31. Amitriptyline/gabapentin

    Case report 02 October 2021 Pages: 31 - 31

32. Amoxicillin

    Case report 02 October 2021 Pages: 32 - 32

33. Amoxicillin/metronidazole

    Case report 02 October 2021 Pages: 33 - 33

34. Amphotericin-B

    Case report 02 October 2021 Pages: 34 - 34

35. Amphotericin-B

    Case report 02 October 2021 Pages: 35 - 35

36. Amphotericin-B/caspofungin

    Case report 02 October 2021 Pages: 36 - 36

37. Amphotericin-B/flucytosine

    Case report 02 October 2021 Pages: 37 - 37

38. Ampicillin/prednisolone

    Case report 02 October 2021 Pages: 38 - 38

39. Anakinra

    Case report 02 October 2021 Pages: 39 - 39

40. Antiepileptic-drugs/GABA-receptor-agonists

    Case report 02 October 2021 Pages: 40 - 40

41. Antifungals/immunosuppressants

    Case report 02 October 2021 Pages: 41 - 41

42. Antineoplastic

    Case report 02 October 2021 Pages: 42 - 42

43. Antineoplastics

    Case report 02 October 2021 Pages: 43 - 43

44. Antineoplastics

    Case report 02 October 2021 Pages: 44 - 44

45. Antineoplastics

    Case report 02 October 2021 Pages: 45 - 45

46. Antineoplastics

    Case report 02 October 2021 Pages: 46 - 46

47. Antineoplastics

    Case report 02 October 2021 Pages: 47 - 47

48. Antineoplastics

    Case report 02 October 2021 Pages: 48 - 48

49. Antipsoriatics/corticosteroids

    Case report 02 October 2021 Pages: 49 - 49

50. Antipsychotics

    Case report 02 October 2021 Pages: 50 - 50